Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial

The aim of the study was to evaluate the overall biohumoral and metabolic effects of a 12-week add-on therapy consisting of a new nutraceutical formulation (BHC) based on berberine, hesperidin, and chromium picolinate in type 2 diabetes mellitus (T2D) patients with suboptimal glycemic compensation r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartore, Giovanni, Ragazzi, Eugenio, Antonello, Giulia, Cosma, Chiara, Lapolla, Annunziata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308828/
https://www.ncbi.nlm.nih.gov/pubmed/34371883
http://dx.doi.org/10.3390/nu13072373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308828/
https://www.ncbi.nlm.nih.gov/pubmed/34371883
http://dx.doi.org/10.3390/nu13072373

Ejemplares similares